Similar Papers

Paper Title
Journal
Date
Author
Abstract P6-06-01: High-grade human cytomegalovirus IEA is associated with expression of COX-2 and 5-LO in human breast cancer samples
H Costa ... B Davoudi
Cancer Research | VOL. 77
H Costa, et. al.H Costa ... B Davoudi
14 Feb 2017
Author response: Acid-base transporters and pH dynamics in human breast carcinomas predict proliferative activity, metastasis, and survival
Nicolai J Toft ... Mark Burton
-
Nicolai J Toft, et. al.Nicolai J Toft ... Mark Burton
06 Jun 2021
Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer
Helena Costa ... Cecilia Söderberg-Naucler
Journal of Cancer Research and Clinical Oncology | VOL. 145
Helena Costa, et. al.Helena Costa ... Cecilia Söderberg-Naucler
15 Jun 2019
P53 protein accumulation and mutations in normal and benign breast tissue.
Rita Kandel ... Tom Rohan
International journal of cancer | VOL. 87
Rita Kandel, et. al.Rita Kandel ... Tom Rohan
01 Jan 1999
View more papers

More From: Cancer Research

Paper Title
Journal
Date
Author
Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer.
Chenyang Zhang ... Zhao Zhang
Cancer research | VOL. -
Chenyang Zhang, et. al.Chenyang Zhang ... Zhao Zhang
04 Feb 2025
Ribosomal RNA Biosynthesis Functionally Programs Tumor-Associated Macrophages to Support Breast Cancer Progression.
Brandon J Metge ... Lalita A Shevde
Cancer research | VOL. -
Brandon J Metge, et. al.Brandon J Metge ... Lalita A Shevde
04 Feb 2025
JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer.
Chuanjie Zhang ... Yi Gao
Cancer research | VOL. -
Chuanjie Zhang, et. al.Chuanjie Zhang ... Yi Gao
04 Feb 2025
Scavenger Receptor CD36 in Tumor-Associated Macrophages Promotes Cancer Progression by Dampening Type-I IFN Signaling.
Ziyan Xu ... Susan M Kaech
Cancer research | VOL. 85
Ziyan Xu, et. al.Ziyan Xu ... Susan M Kaech
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.